These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4141051)

  • 1. [Treatment of prostatic adenoma with medroxyprogesterone acetate].
    Maltoni G; Zoli M
    Minerva Urol; 1972; 24(5):184-99. PubMed ID: 4141051
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience with medroxyprogesterone acetate in adenoma of the prostate].
    Sesia G; Ferrando U; Laudi M; Fontana G
    Minerva Urol; 1970; 22(3):81-8. PubMed ID: 4099513
    [No Abstract]   [Full Text] [Related]  

  • 3. [Medical treatment of prostatic adenoma].
    Schulman CC; Chantrie M; Giannakopoulos X; De Sloover CR
    Brux Med; 1979 Oct; 59(10):467-70. PubMed ID: 94841
    [No Abstract]   [Full Text] [Related]  

  • 4. [Medroxyprogesterone acetate in urinary retention caused by inoperable prostatic hypertrophy].
    Menozzi D; Debbia F
    Minerva Urol; 1970; 22(3):89-105. PubMed ID: 4099514
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of prostatic adenoma with phytosterols].
    Bauer KM; Otto G
    Med Welt; 1975 Jan; 26(1):7-10. PubMed ID: 48990
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tadenan in the treatment of prostatic adenoma. Anatomo-clinical study].
    Bongi G
    Minerva Urol; 1972; 24(4):129-39. PubMed ID: 4141048
    [No Abstract]   [Full Text] [Related]  

  • 7. [Double-blind test on the therapeutic effects of a prostatic extract in the clinical syndrome of prostatic adenoma].
    Arduini M; Trucchi E
    Minerva Urol; 1972; 24(5):167-72. PubMed ID: 4141050
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of prostatic hypertrophy with synthetic progestational hormones].
    Apicella F; Romanelli B
    Minerva Urol; 1971; 23(5):220-4. PubMed ID: 4110157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medroxy-progesterone acetate and bladder neoplasms].
    Francone E
    Minerva Urol; 1974; 26(1):32-44. PubMed ID: 4609065
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hormonal treatment of prostatic hypertrophy with special reference to the usefulness of gestagens].
    Musierowicz A
    Wiad Lek; 1974 Nov; 27(22):1985-8. PubMed ID: 4140619
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of prostatic cancer: medroxyprogesterone acetate, diethylstilbestrol and cyproterone acetate. Provisional report of a random study by the genito-urinary cooperative group of the EORTC].
    Pavone-Macaluso M; Martínez-Piñeiro JA; de Voogt H; Lardennois B; Nasta A; Zolfanelli R; Barasolo E; De Pauw M; Suciu S; Sulvester R
    Arch Esp Urol; 1982; 35(5):304-11. PubMed ID: 6217788
    [No Abstract]   [Full Text] [Related]  

  • 12. [Gestonorone therapy of prostatic adenoma].
    Lopatkin N; Darenkow A; Sahmatow J; Tankó A; Ignaschin N; Warentsow G
    Acta Chir Acad Sci Hung; 1980; 21(4):271-8. PubMed ID: 6175122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of advanced prostatic carcinoma with medroxyprogesterone.
    Rafla S; Johnson R
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):261-7. PubMed ID: 4208339
    [No Abstract]   [Full Text] [Related]  

  • 14. [Raveron treatment of prostatic adenoma in the light of uroflowmetry (on the basis of 20 cases)].
    Janosz F; Zieliński J
    Pol Przegl Chir; 1975 Nov; 47(11A):1441-4. PubMed ID: 54910
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of mepartricin on prostatic adenoma].
    Pellet B; Granata F; von Niederhäusern W
    Rev Med Suisse Romande; 1980 Nov; 100(11):899-903. PubMed ID: 6162182
    [No Abstract]   [Full Text] [Related]  

  • 16. [Non-emergency indications for prostatic adenomectomy].
    Bouffioux C; Demelenne A; Jadot J; Desirotte J; Pontus T
    Acta Urol Belg; 1979 Jul; 47(3):498-505. PubMed ID: 92886
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of amino acids as a combination in the treatment of prostatic hypertrophy].
    Menéndez Fernández H; Castillo Vergara P; Hilario García Marcos J; Romero Gil JR
    Arch Esp Urol; 1988 Sep; 41(7):495-9. PubMed ID: 2468315
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of prostatic cancer with progestational agents].
    Bouffioux C
    Acta Urol Belg; 1976 Oct; 44(4):336-53. PubMed ID: 1026071
    [No Abstract]   [Full Text] [Related]  

  • 19. Current role of alpha-blockers in the treatment of benign prostatic hyperplasia.
    Kaplan SA
    BJU Int; 2008 Nov; 102 Suppl 2():3-7. PubMed ID: 19032603
    [No Abstract]   [Full Text] [Related]  

  • 20. [Action of the combination of hypothalamic phospholipids and megestrol acetate (IP 11) in prostatic hypertrophy. Results of a controlled clinical trial].
    Mazza G; Petracco S
    Minerva Urol; 1974; 26(6):293-300. PubMed ID: 4142804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.